Literature DB >> 29661680

Individual-level key associations and modes of exposure for hepatitis C virus infection in the Middle East and North Africa: a systematic synthesis.

Sarwat Mahmud1, Silva P Kouyoumjian1, Zaina Al Kanaani1, Hiam Chemaitelly1, Laith J Abu-Raddad2.   

Abstract

PURPOSE: To identify, map, and synthesize the individual-level key associations and modes of exposure for hepatitis C virus (HCV) infection in the Middle East and North Africa (MENA), the most affected region by HCV.
METHODS: Source of data was the MENA HCV Epidemiology Synthesis Project database, populated through systematic literature searches. Risk factors determined to be statistically significant after adjustment for confounders were extracted and categorized into key associations or modes of exposure.
RESULTS: In total, 329 risk factors were identified from 109 articles in 14 of 24 MENA countries. Among key associations, age was most frequently reported (n = 39; 34.2%), followed by other infections/diseases (n = 20; 17.5%), and incarceration (n = 17; 14.9%). Among modes of exposure, health care-related exposures were most frequently reported (n = 127; 59.5%), followed by injecting drug use exposures (n = 45; 20.9%), community-related exposures (n = 34; 15.8%), and sexual-related exposures (n = 8; 3.7%). Blood transfusion, hemodialysis, surgical and other medical procedures, dental work, and medical injections were identified as key health care-related exposures.
CONCLUSIONS: Health care appears to be the primary driver of prevalent (and possibly incident) infections in MENA, followed by injecting drug use. HCV screening should target the identified modes of exposure. Commitment to prevention should be an integral component of HCV response to achieve HCV elimination by 2030, with focus on strengthening infection control in health care facilities, improving injection safety and blood screening, and expanding harm reduction services for people who inject drugs.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cohort study; Cross-sectional study; HCV; Mode of transmission; Risk behavior; Viral hepatitis

Mesh:

Year:  2018        PMID: 29661680     DOI: 10.1016/j.annepidem.2018.03.007

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  6 in total

Review 1.  HCV Burden and Barriers to Elimination in the Middle East.

Authors:  Sarah Blach; Faisal M Sanai
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-01-29

Review 2.  Cross-transmission in the Dental Office: Does This Make You Ill?

Authors:  C M C Volgenant; J J de Soet
Journal:  Curr Oral Health Rep       Date:  2018-10-25

3.  The epidemiology of hepatitis C virus in Central Asia: Systematic review, meta-analyses, and meta-regression analyses.

Authors:  Welathanthrige S P Botheju; Fawzi Zghyer; Sarwat Mahmud; Assel Terlikbayeva; Nabila El-Bassel; Laith J Abu-Raddad
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

4.  The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa.

Authors:  Sarwat Mahmud; Ghina R Mumtaz; Hiam Chemaitelly; Zaina Al Kanaani; Silva P Kouyoumjian; Joumana G Hermez; Laith J Abu-Raddad
Journal:  Addiction       Date:  2020-02-03       Impact factor: 6.526

Review 5.  Who to Test for Hepatitis C Virus in the Middle East and North Africa?: Pooled Analyses of 2,500 Prevalence Measures, Including 49 Million Tests.

Authors:  Hiam Chemaitelly; Sarwat Mahmud; Silva P Kouyoumjian; Zaina Al-Kanaani; Joumana G Hermez; Laith J Abu-Raddad
Journal:  Hepatol Commun       Date:  2019-01-23

6.  Key associations for hepatitis C virus genotypes in the Middle East and North Africa.

Authors:  Sarwat Mahmud; Hiam S Chemaitelly; Silva P Kouyoumjian; Zaina Al Kanaani; Laith J Abu-Raddad
Journal:  J Med Virol       Date:  2019-10-14       Impact factor: 2.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.